Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

December 17, 2023 17:42 (London Time)

Illumina

Youtube Subscribe

...

Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.8412
MarketCap: 20,183,480,000.0
High: 134.34 Low: 126.82

Open: 133.71 Close: 127.1 Change: -6.61

Are you looking for information about Illumina Company Inc? We programmed an AI to summarize it for you.

The game is changing. There is a new strategy to evaluate Illumina fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, file, Court, rating, SEC, company, coverage, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers sequencing and array-based instruments and consumables, which include reagents, flow.

Today's Summary

Illumina announced Monday it filed a draft registration statement with the U.S. Fifth Circuit Court of Appeals. Court sides with ftc finding Illumina-grail deal anticompetitive. Judges also fault agency for not properly considering Illuminas plan to fix drawbacks.

Today's News

Court sides with ftc finding Illumina-grail deal anticompetitive. Judges also fault agency for not properly considering Illuminas plan to fix drawbacks. Illumina submits Form 10 to the Securities and Exchange Commission Illumina, Inc. SEC filing. The Wall Street Journal Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive. Illumina announced Monday it filed a draft registration statement with the U.S. Fifth Circuit Court of Appeals. Illumina ( NASDAQ: ILMN ) announced Monday. It filed a. draft registration statements with the. Fifth Circuit. Court of. Appeals rules against the company, Illumina. will proceed with the companys divestiture. Illumina Lights Linx Necklace - Brighton X WELCOME TO THE SALE! Illumina (NASDAQ:ilmn) receives new coverage from analysts at stephens - defense world. Citigroup raised shares of Illumina from a sell rating to a neutral rating. StockNews.com began coverage on Illumina in a report on Thursday. Illumina will be transitioning to a source-to-pay solution from SAP Ariba. Suppliers choosing to transact with Illumina using an enterprise account incur costs in the form of fees. Illumina preferred and currently only method available to integrate source to pay transactions with our suppliers is thru Ariba Network. We have teams dedicated to supporting you through this process. Illumina Genotyping Array Pipeline is available on the cloud-based platform Terra. BafRegress software uses a regression model to detect and estimate sample contamination. VerifyIDIntensity requires an adpc.bin file (a binary file containing array intensity data) as input. Stephens & Co. analyst Mason Carrico initiates coverage on Illumina with a Overweight rating and announces Price Target of $170. Citigroup upgrades Illumina from Sell to Neutral and raises the price target from $85 to $120. Illumina stock has received a consensus rating of buy. According to the current price, Illumina is 143.07% away from the 52-week low. The 58 analysts offering price forecasts for Illumina have a median target of 247.16. Illumina is improving human health by unlocking the power of the genome. The company has been named to the Dow Jones Sustainability World Index and the North America Index for 2023 in the Life Sciences Tools & Services Industry. Illumina submits SEC form for grail divestiture - marketwatch.com. European Commission on Thursday ordered Illumina to divest Grail, opening the next chapter in the years-long regulatory saga. Illumina was ordered in October to unwind its $7.1 billion. Astellas Withdraws IRA Lawsuit, New Illumina CEO Jacob Thaysen replaces Francis deSouza. SEC investigating Illuminas acquisition of cancer diagnostics company GRAIL. Illumina stock downgraded at bofa on growth concerns | seeking alpha. Illumina cut to Underperform at BofA on growth concern Dec. 12, 2023 7:59 AM ET.

Stock Profile

"Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California."

Keywords

This document will help you to evaluate Illumina without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, file, Court, rating, SEC, company, coverage, and the most common words in the summary are: illumina, learn, sequence, news, new, product, tool, . One of the sentences in the summary was: Judges also fault agency for not properly considering Illuminas plan to fix drawbacks.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #illumina #learn #sequence #news #new #product #tool.

Read more →

Related Results

...
March 14, 2024 15:18 (London Time)

Illumina

Carl Icahn has decided not to launch a fresh proxy fight at DNA sequencing company Illumina Inc. Icahn said on Monday that he plans to oust director…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.5684
MarketCap: 21,098,742,000.0
High: 133.2 Low: 129.95

Open: 131.94 Close: 130.09 Change: -1.85

Read more →
...
December 30, 2023 4:16 (London Time)

Illumina

Illumina Inc. stock underperforms thursday when compared to competitors - marketwatch.com. ILMN -2.03% SPX -0.28% DJIA - 0.05% LH +0.10% CRL -1.00% …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9922
MarketCap: 22,117,664,000.0
High: 142.76 Low: 138.5

Open: 141.22 Close: 139.24 Change: -1.98

Read more →
...
December 17, 2023 17:42 (London Time)

Illumina

Illumina announced Monday it filed a draft registration statement with the U.S. Fifth Circuit Court of Appeals. Court sides with ftc finding Illumin…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.8412
MarketCap: 20,183,480,000.0
High: 134.34 Low: 126.82

Open: 133.71 Close: 127.1 Change: -6.61

Read more →
...
December 06, 2023 1:49 (London Time)

Illumina

Illumina inc. stock outperforms market on strong trading day. Company size 5,001-10,000 employees. Illumina provides array-based solutions for DNA, …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9011
MarketCap: 18,157,192,000.0
High: 114.86 Low: 110.77

Open: 113.07 Close: 111.76 Change: -1.31

Read more →
...
October 15, 2023 19:45 (London Time)

Illumina

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer screening company Grail. EU antitrust regulators on Thursday ordered Illu…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.8345
MarketCap: 20,430,198,000.0
High: 130.34 Low: 127.58

Open: 129.65 Close: 129.11 Change: -0.54

Read more →
...
June 17, 2023 14:51 (London Time)

Illumina

Francis deSouza steps down as CEO of Illumina amid a bruising battle with regulators to acquire Grail, the cancer blood test startup. Activist inves…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9859
MarketCap: 32,548,047,000.0
High: 212.49 Low: 205.0

Open: 212.1 Close: 205.87 Change: -6.23

Read more →
...
May 22, 2023 14:09 (London Time)

Illumina

Carl Icahn launched a proxy battle against Illumina last month. Icahn concedes Illumina is a “great company,” even though he is. Illumina trades at …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.8016
MarketCap: 34,564,469,952.0
High: 209.15 Low: 205.03

Open: 201.93 Close: 207.31 Change: 5.38

Read more →
...
May 04, 2023 1:51 (London Time)

Illumina

Carl Icahn calls Illumina Q1 results ‘very disappointing, slams cost-cutting plan. Icahn is engaged in a proxy contest with the DNA sequencing firm.…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9881
MarketCap: 31,063,539,712
High: 201.65 Low: 195.25

Open: 195.96 Close: 196.54 Change: 0.58

Read more →
...
January 21, 2024 13:01 (London Time)

Illumina

Illumina (NASDAQ:ILMN) had a negative net margin of 25.20% and a positive return on equity of 2.13% The average price target for Illumina is $142.72…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.705
MarketCap: 21,577,744,000.0
High: 136.75 Low: 132.55

Open: 134.0 Close: 135.88 Change: 1.88

Read more →
...
December 21, 2023 1:54 (London Time)

Illumina

Illumina hopes to finalize divestiture terms by the end of the second quarter of 2024. Activist investor Carl Icahn waged a proxy battle with Illumi…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.9423
MarketCap: 22,165,304,000.0
High: 143.74 Low: 136.8

Open: 139.0 Close: 136.9 Change: -2.1

Read more →
...
December 08, 2023 21:55 (London Time)

Illumina

Illumina stock price fell $4.64 - or 5.6%, to close at $124 per share on October 18,23. Carl Icahn filed a complaint alleging direct and derivative …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.8807
MarketCap: 18,600,244,000.0
High: 117.52 Low: 112.9

Open: 116.22 Close: 112.94 Change: -3.28

Read more →
...
November 04, 2023 5:39 (London Time)

Illumina

Portnoy Law Firm advises Illumina, Inc. (NASDAQ:ILMN) investors that the firm has initiated an investigation into possible securities violations.
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.743
MarketCap: 17,770,758,000.0
High: 118.38 Low: 114.96

Open: 114.96 Close: 116.92 Change: 1.96

Read more →
...
August 15, 2023 4:01 (London Time)

Illumina

Illumina reported flat year-over-year second-quarter revenues, lowered 2023 revenue and earnings per share guidance. Firm was fined 432 million euro…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.7788
MarketCap: 28,569,984,000.0
High: 179.44 Low: 174.35

Open: 178.31 Close: 175.14 Change: -3.17

Read more →
...
June 09, 2023 16:41 (London Time)

Illumina

Illumina CEO survived a challenge to his board seat from activist investor Carl Icahn last week. Icahn mustered enough shareholder support to oust b…
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: -0.0397
MarketCap: 32,050,032,000.0
High: 202.4 Low: 199.62

Open: 201.67 Close: 200.49 Change: -1.18

Read more →
...
May 14, 2023 16:13 (London Time)

Illumina

Illumina shareholders are up 6.6% this past week, but still in the red over the red. Shares of Illumina jumped as much as 7.2% in Wednesday morning …
Sector: Life Sciences Tools & Services
Ticker: ILMN
Sentiment: 0.9955
MarketCap: 34,564,469,952.0
High: 211.61 Low: 206.76

Open: 209.34 Close: 208.6 Change: -0.74

Read more →